Acquisitions, Expediting Clinical Trials, Earnings Release, Technical Updates, Divesture Approval - Research Reports on Google, Verizon, Autodesk, Baidu and IBM

NEW YORK, August 20, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Google Inc. (NASDAQ: GOOG), Verizon Communications Inc. (NYSE: VZ), Autodesk, Inc. (NASDAQ: ADSK), Baidu, Inc. (NASDAQ: BIDU) and International Business Machines Corporation (NYSE: IBM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5850-100free.

--
Google Inc. Research Reports
On August 15, 2014, TechCrunch reported that Google Inc. (Google) has acquired the team behind Jetpac. As per the TechCrunch report, the Company is expected to use the Jetpac team to enhance search around location information by photo data. According to the article, Jetpac's CTO Pete Warden is a computer vision professional and a perfect fit for a Google acquisition at this juncture. The report highlighted that Jetpac's system locates visual signs, for instance the amount of pictures with mustaches in them to conclude the fashion style or how many hipsters are in a particular site. This provides distinctive background information about an area where the photo was taken. Jetpac has also attained real-time local object recognition on video from a phone's camera. This technology could conceivably augment Google Goggles. According to the TechCrunch report, Jetpac will soon be drawing out the app from the App store in the coming days and will cease the support on September 15, 2014. The full research reports on Google are available to download free of charge at:

http://www.analystsreview.com/Aug-20-2014/GOOG/report.pdf

--
Verizon Communications Inc. Research Reports
On August 12, 2014, Verizon Communications Inc. (Verizon) aided The University of Virginia's Center for Diabetes Technology and the Stanford University School of Medicine to conduct clinical trials on children with type 1 diabetes. According to the Company, using Verizon's network technology, campers aged 7 to 17 participated in a clinical trial of an artificial pancreas at a diabetes summer camp in Boulder Creek, California. The artificial pancreas is a system that calculates blood glucose levels every few minutes, through a continuous glucose monitor. A smartphone with distinctive software then transmits this information to an insulin pump that computes and can release the requisite amount of insulin into the body. To enable the entire process, Verizon is offering the underlying technology via its Wireless Private Network with 4G LTE access and secure Private IP network along with the its HIPAA-enabled Data Center Services, permitting the researchers to securely trace, access and stock patient data from the trial. The full research reports on Verizon are available to download free of charge at:

http://www.analystsreview.com/Aug-20-2014/VZ/report.pdf

--
Autodesk, Inc. Research Reports
On August 14, 2014, Autodesk, Inc. (Autodesk) reported financial results for Q2 FY 2015 (period ended July 31, 2014). Total net revenue inclined to $637.1 million, up 13.4% YoY. Carl Bass, Autodesk's President and CEO, said, "Strong demand on a global basis and expanding adoption of our suites solutions drove strong billings and record revenue results." The non GAAP diluted earnings per share was $0.35 in Q2 FY 2015, as compared to $0.45 in Q2 FY 2014. During the quarter, revenue from the Americas, which contributed 35.0% to the total net revenues, grew 11% YoY to $223 million. Meanwhile, the revenue from Platform Solutions and Emerging Business reached $208 million, up 5% YoY. The Company further expects revenue for Q3 FY 2015 to range between $590- $605 million and for FY 2015 Autodesk expects revenue growth of 7%-9%. The full research reports on Autodesk are available to download free of charge at:

http://www.analystsreview.com/Aug-20-2014/ADSK/report.pdf

--
Baidu, Inc. Research Reports
On August 15, 2014, the stock (ADR) of Baidu, Inc. (Baidu) declined 0.33% to end the trading session at $218.85. During the day, the stock opened at $221.40 and oscillated in a range of $217.09 - $221.5, with total trade volume of 2.53 million. Over the last one month, the stock has increased by 15.54%, compared to the S&P 500 index which declined 1.34% during the same period. As of August 15, 2014, the Company had a market capitalization of $76.8 billion and stock beta of 1.91. The full research reports on Baidu are available to download free of charge at:

http://www.analystsreview.com/Aug-20-2014/BIDU/report.pdf

--
International Business Machines Corporation Research Reports
On August 15, 2014, International Business Machines Corporation (IBM) announced that it has received approval from the Committee on Foreign Investment in the United States (CFIUS) for the divestiture of its x86-based server business to Lenovo. According to IBM, the regulatory clearance on the $2.3 billion deal allows IBM to focus on system and software inventions that transport new kinds of value to IBM clients in areas such as cognitive computing, Big Data and cloud, and delivers lucidity and confidence to current x86 customers that they will have a strong partner ahead. The full research reports on IBM are available to download free of charge at:

http://www.analystsreview.com/Aug-20-2014/IBM/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review